癌症伴骨质疏松患者的临床治疗价值探讨  

Cancer patients palliative care of the osteoporosis treatment

作　　者：董云峰[1] 郭海[1] 

机构地区：[1]北京市房山区第一医院,北京102400

出　　处：《基层医学论坛》2016年第7期872-874,共3页The Medical Forum

摘　　要：目的研究癌症伴骨质疏松患者治疗骨质疏松的临床意义。方法对在我科就诊的癌症患者进行骨密度测定,纳入70例癌症伴骨质疏松的病例,随机分为治疗组和对照组,治疗组行唑来膦酸及骨化三醇联合补充钙剂治疗;对于对照组仅加强含钙饮食,未行药物抗骨质疏松治疗。药物治疗3个月后评价疗效,观察指标为骨密度的变化及骨质疏松最常见的临床症状腰背痛。结果癌症伴骨质疏松患者进行药物治疗能明显提高骨密度值,预防骨质疏松症状的出现。结论对癌症伴骨质疏松患者进行抗骨质疏松的药物治疗安全有效,可提高癌症患者的生存质量,具有姑息治疗意义。Objective Study Cancer patients with osteoporosis of the treatment clinical significance.Methods Measure Cancer patients with bone mineral density,choose70 cases osteoporosis with Cancer patients,divided into treatment group and observation group.Treatment group is given azole to phosphonic acid and calcitriol,supplement calcium.Observation group is only instructed to strengthen calcium diet,no anti osteoporosis treatment.Evaluation of curative effect,3 month after medication observation indexes for the changes of bone mineral density and osteoporosis of the most common clinical symptoms of low back pain.Results Anti osteoporosis therapy to Cancer patients with osteoporosis can significantly elevated in patients with bone mineral density values and prevent osteoporosis symptoms appear.Conclusion Anti osteoporosis treatment is safe and effective for Cancer patients with osteoporosis,Anti osteoporosis treatment can improve the quality of survival in patients with cancer,It have Palliative treatment clinical significance.

关 键 词：癌症患者 骨质疏松 药物治疗 临床意义 

分 类 号：R580[医药卫生—内分泌] R730.5[医药卫生—内科学]